NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 10 Nov 2026, 04:06 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Global Health Limited · MEDANTA

✦ AI SummaryMgmt Change

Global Health Limited has informed the Exchange about a scheduled meeting with investors and analysts on November 19 and 20, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

MEDANTA21_10112026160354_GHLANALYSTSMEETNOVEMBER102026_SIGNED.pdf

pdf

Download →
View document text
Date: November 10, 2026 Ref:- GHL/2026-27/EXCH/ 77 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, P J Towers, Dalal National Stock Exchange of India Limited Street, Mumbai - 400 001, India. Exchange Plaza, C-1, Block G, Bandra Kurla Complex,Bandra (E), Mumbai - 400 051, India. Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting. Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investors/Analysts as per the below schedule: Date of Meeting Name of Investor/Analyst Firm Type of Meeting Mode of Meeting November 19, 2026 HSBC Global Asset Management One to One In Person Veritas Asset Management One to One In Person Schroders Investment Management One to One In Person WFM Asia One to One In Person CI Global Asset Management' One to One In Person November 20, 2026 Wellington Management One to One In Person Invesco One to One In Person Fidelity Management & Research One to One In Person Mirae Asset Global Investments One to One In Person Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319